Semaglutide, the key ingredient of Wegovy and Ozempic known for their weight loss properties went off-patent on Friday, triggering a flood of affordably-priced generic variants from Indian manufacturers. However, the DGCI sees cause for concern, and has alerted states and union territories.
​Semaglutide, the key ingredient of Wegovy and Ozempic known for their weight loss properties went off-patent on Friday, triggering a flood of affordably-priced generic variants from Indian manufacturers. However, the DGCI sees cause for concern, and has alerted states and union territories. by Soban News (international And National News)
